Empowering PMOs with Intelligent Project Management Tools Austin, United States - March 22, 2026 / Upland Software, ...
Lacutamab TELLOMAK-3 confirmatory Phase 3 trial in cutaneous T-cell lymphoma (CTCL) is planned for initiation in H2 2026, subject to non-dilutive financing options currently under negotiation, includi ...
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results